Potassium Citrate Tablet
NDC Package 44523-410-01
Package Information
Potassium Citrate tablets is 1 INDICATIONS AND USAGE1.1 Renal Tubular Acidosis (RTA) with Calcium StonesPotassium Citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1)].1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any EtiologyPotassium Citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies (14.2)].1.3 Uric Acid Lithiasis with or without Calcium StonesPotassium Citrate is indicated for the management of Uric acid lithiasis with or without calcium stones [see Clinical Studies (14.3)]. This formulation utilizes a tablet delivery system. Marketed by Biocomp Pharma, Inc., this product is identified by NDC 44523-410 and is authorized under FDA application NDA019071.
Identification & Billing
- RxCUI: 199381 - potassium citrate 10 MEQ Extended Release Oral Tablet
- RxCUI: 199381 - K+ citrate 10 MEQ Extended Release Oral Tablet
- RxCUI: 199381 - Pot citrate 10 MEQ Extended Release Oral Tablet
- RxCUI: 199381 - potassium citrate 1080 MG Extended Release Oral Tablet
- RxCUI: 898490 - potassium citrate 15 MEQ Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 44523 - Biocomp Pharma, Inc.
- 44523-410 - Potassium Citrate
- 44523-410-01 - 100 TABLET in 1 BOTTLE
- 44523-410 - Potassium Citrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44523-410-01 identifies a specific commercial package of 100 tablet in 1 bottle of Potassium Citrate, a human prescription drug labeled by Biocomp Pharma, Inc.. This tablet is formulated for oral use and contains potassium citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biocomp Pharma, Inc. on December 03, 2024. The current certification is valid through December 31, 2026.
How is this Biocomp Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44523041001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.